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TO THE EDITOR
Galli-Galli disease (GGD; Online Men-
delian Inheritance in Man (OMIM) not
assigned) is a rare autosomal dominant
disorder with variable penetrance and
frequently sporadic occurrence. The
disease was first described in two
brothers and named after them (Bardach
et al., 1982). Nowadays GGD is as-
sumed to be a variant of Dowling-Degos
disease (DDD) as it is allelic with DDD
(OMIM 179859) (Braun-Falco et al.,
2001; Sprecher et al., 2007). DDD is
an autosomal dominant disorder char-
acterized by hyperpigmented macules
distributed in a generalized reticulate
pattern, particularly affecting the flex-
ures. GGD and DDD share the clinical
features of reticulate or patchy hyper-
pigmentation, mainly in flexural areas,
but distinction has been made by
histological examination (El Shabrawi-
Caelen et al., 2007b). Both of them are
characterized by downward prolifera-
tion of digitate rete ridges. Nonetheless,
in GGD focal acantholysis and supra-
basal lacunae may be observed, features
classically not associated with DDD
(El Shabrawi-Caelen et al., 2007a; Muller
et al., 2009). This distinction has re-
cently been questioned by Hanneken
et al. (2010), who demonstrated that
many cases diagnosed as DDD showed
epidermal acantholysis. It could be
argued that the point of time of the
biopsy determines whether acantholysis
is seen or not.
The genetic background of DDD has
been linked to the Keratin 5 (KRT5)
gene in genome-wide linkage analysis
in two families with the loss-of-function
mutation, c.418dupA (p.Ile140AsnfsX39;
Betz et al., 2006). Further mutations in
the KRT5 gene in DDD have been
reported afterwards (Liao et al., 2007;
Guo et al., 2011). It has to be empha-
sized that by far not in all patients
with DDD a KRT5 mutation could be
revealed (Asahina et al., 2007). The
mutation c.418dupA was found in eight
further patients, two of them having been
diagnosed as GGD (Hanneken et al.,
2010). By correlating genotypes with
phenotypes it has been documented
that patients with the KRT5 mutation
c.418dupA present reticular hyperpig-
mentation in the flexural areas, whereas
in patients with a more disseminated
pattern consisting of hyperpigmented
lentiginous maculae this mutation could
not be found. Sprecher et al. (2007)
identified a mutation in the KRT5 gene,
cT2C (p.M1?), which leads to haplo-
insufficiency of keratin 5 (K5) in a patient
with GGD. This prompted the assump-
tion that the two entities reflect clinical
and histological variants of the same
disease spectrum (Sprecher et al., 2007).
We describe a 44-year-old woman
with a 4-year history of patchy hyper-
pigmented, slightly scaly, sharply de-
marcated macules on her left thigh
showing a segmental arrangement
(Figure 1a and b). The macules were
completely asymptomatic. No blister-
ing was reported. The skin between the
brownish macules appeared to be
normal. General skin examination re-
vealed no pathologic findings. In parti-
cular, the skin folds were not involved.
She had two unaffected children, 7 and
9 years old. Her younger sister and her
parents were not affected either. In light
microscopy, the typical GGD features
were demonstrated in the affected area,
notably acantholysis, down growing of
rete ridges, hyperpigmentation of basal
keratinocytes, and hyperparakeratosis
(Figure 2a). By electron microscopy,
only perilesional areas and no proper
blister regions were available for in-
vestigation and revealed acantholysis in
suprabasal keratinocytes (Figure 2b).
There was no evidence for cytolysis in
basal keratinocytes, which is normally
present in epidermolysis bullosa sim-
plex (EBS) blisters.
Because our patient showed a seg-
mental arrangement of brownish
macules without generalized affection,
we assumed that she has a type 1
segmental inherited disease. To explain
segmental disorders in monogenic traits,
a type 1 and type 2 segmental manifesta-
tion have been proposed (Happle, 1993,
1996). In autosomal dominant disorders,
a type 1 segmental involvement reflects
a postzygotic mutation in an otherwise
genetically healthy embryo, whereas a
Abbreviations: DDD, Dowling-Degos disease; EBS, epidermolysis bullosa simplex; GGD, Galli-Galli
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type 2 segmental involvement results
from a postzygotic loss of heterozygosity
in a heterozygous embryo implying loss
of the corresponding wild-type allele. In
type 1 segmental disorders, only the
mutated segment is clinically affected,
whereas in type 2 segmental disorders
one segment is more affected than the
rest of the skin, showing nonsegmental
features of the same disease.
After informed consent, EDTA-blood
was obtained from the patient. The
study was approved by the Ethics
Committee of the University of Freiburg
and conducted according to the De-
claration of Helsinki Principles. We first
isolated DNA from peripheral blood
leukocytes by use of the Qiagen blood
minikit (Qiagen, Hilden, Germany). All
exons and the neighboring intronic
regions of KRT5 (GenBank accession
number NM_000424.2), and of KRT14
(GenBank accession number NM_
000526.3) were amplified by PCR and
sequenced as described previously
(Schuilenga-Hut et al., 2003) on an ABI
prism 3100 automated sequencer (ABI,
Darmstadt, Germany). However, no
mutation was disclosed in either gene.
For further investigation two skin samples
were obtained: one from the clinically
affected area on the left thigh and another
from an unaffected area on the back.
Hematoxylin–eosin staining was per-
formed with standard procedures. Indirect
immunofluorescence of skin cryosections
was performed with mAbs anti-human
keratin 5 (Clone D5/16 B4, Dako, Ham-
burg, Germany) and keratin 14 (Clone
LL002, BioGenex, San Ramon, CA) as
previously described (Has et al., 2006).
The staining pattern with both antibodies
was similar to the staining of control
human skin (not shown).
For DNA recovery by laser dissec-
tion microscopy (LDM), skin cryosec-
tions of 5 mm were mounted on 1.0 mm
olyethylene naphthalate-membrane
covered slides (Zeiss, Go¨ttingen,
Germany). Keratinocytes of an acantho-
lytic and a non-acantholytic area were
dissected by use of the Laser Robot
Microbeam System (P.A.L.M. Microla-
ser Technology AG, Bernried, Germany)
and directly collected in the caps of
0.5-ml thin-wall reaction tubes (Zeiss).
Thirty ml of a mix consisting of PCR
buffer (JumpStart RED Taq DNA Poly-
merase; Sigma-Aldrich, Munich, Germany),
water, and proteinase K (Qiagen) were
added. Approximately 200 cells micro-
dissected from the epidermis were
collected in a 0.5-ml reaction tube.
During digestion by proteinase K, the
tubes remained inverted for 60 minutes
at 551C; subsequent heating to 981C for
15 minutes inactivated the proteinase K.
The final aliquots were used for PCR.
For detection of mutations in LDM-
isolated DNA, we used nested PCR. The
first amplification was performed with
KRT5 primers for routine mutation
detection (1F: 50-gagctctgttctctccag-30,
1R: 50-ccttctttctctctctttggc-30). For the
second PCR, 2.5ml of the first PCR
product was used, and the following
primers F: 50-tctccagcacctcccaacccac-
30, R: 50-tcgtagctcaccttgtcgatgaagg-30
were used. PCR cycling conditions were
5 minutes at 941C, followed by 35
cycles at 941C for 45 seconds, 601C for
45 seconds, and 721C for 1 minute and a
final extension at 721C for 10 minutes.
Water, instead of DNA, was used as a
negative control. All PCRs were re-
peated with templates from at least
three separate DNA isolations obtained
by LDM, and all products were sequen-
ced in both directions.
KRT5 mutation analysis performed
with gDNA extracted from the acantho-
lytic epidermal area disclosed a mutation
c.476C4T in a heterozygous state
(Figure 2c). This leads to substitution of
proline with leucine at the position 159
(p.P159L) in the K5 polypeptide. The
variant was excluded in the gDNA
extracted from clinically unaffected skin
and EDTA-blood of the patient. The
previously unreported KRT5 allele was
screened on 200 population-matched
control samples to rule out the possibility
that the putative mutation might be a
frequent polymorphism.
Proline 159 is strongly conserved and
located in the head domain of the K5
a
b
Figure 1. Clinical features of segmental mosaicism. (a, b) Segmental arrangement of light brown and
erythematous macules with fine scales on the left thigh.
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polypeptide, 10 amino acids upstream
from the rod domain. The amino-acid
exchange is predicted to render the
affected copy non-functional. Substitu-
tions in the neighboring positions,
p.D158V and p.I161S, were reported in
patients with EBS (Chan et al., 1993;
Yasukawa et al., 2006). All of these
findings argue in favor of an etiologic role
of the mutation p.P159L, as identified in a
mosaic pattern in this patient, attesting a
previously unreported type 1 segmental
manifestation of GGD. More genotype–-
phenotype correlations are needed to
sustain an association between the muta-
tion p.159L and this particular phenotype
of GGD.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Peter Haeusermann, Dermatology
Department, University Hospital Basel, for taking
histopathological photographs.
Andreas W. Arnold1,2,5,
Dimitra Kiritsi1,5, Rudolf Happle1,
Ju¨rgen Kohlhase3, Ingrid Hausser4,
Leena Bruckner-Tuderman1,
Cristina Has1 and Peter H. Itin2
1Department of Dermatology, Freiburg
University Medical Center, Freiburg, Germany;
2Department of Dermatology, University
Hospital, Basel, Switzerland; 3Center for
Human Genetics, Freiburg, Germany and
4Department of Dermatology, University of
Heidelberg, Heidelberg, Germany
E-mail: aarnold@nhbs.ch
5These authors contributed equally to this work.
REFERENCES
Asahina A, Ishii N, Kai H et al. (2007) Dowling-
Degos disease with asymmetrical axillary
distribution and no KRT 5 exon 1 mutation.
Acta Derm Venereol 87:556–7
Bardach H, Gebhart W, Luger T (1982) Genoder-
matosis in a pair of brothers: Dowling-Degos,
Grover, Darier, Hailey-Hailey or Galli-Galli
disease?. Hautarzt 33:378–83
Betz RC, Planko L, Eigelshoven S et al. (2006)
Loss-of-function mutations in the keratin 5
gene lead to Dowling-Degos disease. Am J
Hum Genet 78:510–9
Braun-Falco M, Volgger W, Borelli S et al.
(2001) Galli-Galli disease: an unrecognized
entity or an acantholytic variant of Dowling-
Degos disease? J Am Acad Dermatol 45:
760–3
Chan YM, Yu QC, Fine JD et al. (1993) The
genetic basis of Weber-Cockayne epidermo-
lysis bullosa simplex. Proc Natl Acad Sci
USA 90:7414–8
El Shabrawi-Caelen L, Hofer A, Kerl H (2007a)
Macro-micro dermatology: erythematous
papules and lentigo-like macules—a new
entity? J Dtsch Dermatol Ges 5:645–6
a
b
c
Lymphocytes
Unaffected skin—trunk
Unaffected skin—left leg
Affected skin—–left leg
lle Asp lleSerLeu
Pro159Leu
lle Asp Pro Ser lle
Figure 2. Morphological analysis of the affected skin and mutation detection. (a) Hyperparakeratosis overlying filiform down growth of rete ridges into the
dermis and acantholysis. Hyperpigmentation of basal keratinocytes is most conspicuous above the dense, mainly lymphocytic infiltrate in the upper dermis (light
microscopy, hematoxylin–eosin staining; upper figure: bar¼500 mm, lower figure: bar¼100 mm). The white-framed area correlates to the electron microscopy
in b. (b) Acantholytic area with intercellular desintegration (and no cytolysis) of suprabasal cells (electron microscopy; left figure: bar¼ 2,500 nm, right figure:
bar¼ 1,000 nm). (c) Identification of the disease-causing mutation in the Keratin 5 (KRT5) gene. The mutation c.476C4T/p.Pro159Leu was identified in a
heterozygous state only in the acantholytic section of the biopsy from the left leg. The normal-looking skin surrounding the acantholytic epidermis and the
unaffected skin from the trunk showed no KRT5 mutation.
2102 Journal of Investigative Dermatology (2012), Volume 132
AW Arnold et al.
Type 1 Segmental Galli-Galli Disease
El Shabrawi-Caelen L, Rutten A, Kerl H (2007b)
The expanding spectrum of Galli-Galli dis-
ease. J Am Acad Dermatol 56:S86–91
Guo L, Luo X, Zhao A et al. (2011) A novel
heterozygous nonsense mutation of keratin 5
in a chinese family with Dowling-Degos
disease. J Eur Acad Dermatol Venereol;
e-pub ahead of print 14 May 2011
Hanneken S, Rutten A, Pasternack SM et al. (2010)
Systematic mutation screening of KRT5 sup-
ports the hypothesis that Galli-Galli disease is
a variant of Dowling-Degos disease. Br J
Dermatol 163:197–200
Happle R (1993) Mosaicism in human skin:
understanding the patterns and mechanisms.
Arch Dermatol 129:1460–70
Happle R (1996) Segmental forms of autosomal
dominant skin disorders: different types of
severity reflect different states of zygosity.
Am J Med Genet 66:241–2
Has C, Chang YR, Volz A et al. (2006) Novel
keratin 14 mutations in patients with severe
recessive epidermolysis bullosa simplex.
J Invest Dermatol 126:1912–4
Liao H, Zhao Y, Baty DU et al. (2007) A
heterozygous frameshift mutation in the
V1 domain of keratin 5 in a family with
Dowling-Degos disease. J Invest Dermatol
127:298–300
Muller CS, Pfohler C, Tilgen W (2009) Chang-
ing a concept—controversy on the con-
fusing spectrum of the reticulate pigmented
disorders of the skin. J Cutan Pathol 36:
44–8
Schuilenga-Hut PH, Vlies P, Jonkman MF
et al. (2003) Mutation analysis of the
entire keratin 5 and 14 genes in patients
with epidermolysis bullosa simplex and iden-
tification of novel mutations. Hum Mutat
21:447
Sprecher E, Indelman M, Khamaysi Z et al. (2007)
Galli-Galli disease is an acantholytic variant
of Dowling-Degos disease. Br J Dermatol
156:572–4
Yasukawa K, Sawamura D, Goto M et al. (2006)
Epidermolysis bullosa simplex in Japanese
and Korean patients: genetic studies in
19 cases. Br J Dermatol 155:313–7
Aedes aegypti Saliva Enhances Dengue Virus Infection of
Human Keratinocytes by Suppressing Innate Immune
Responses
Journal of Investigative Dermatology (2012) 132, 2103–2105; doi:10.1038/jid.2012.76; published online 5 April 2012
TO THE EDITOR
Dengue virus (DENV) is at present the
most important emerging arbovirus.
The incidence of DENV infection has
grown markedly around the world in
recent decades because of expanding
geographic distribution of the virus and
their mosquito vectors, Aedes (Ae.)
aegypti and Ae. albopictus. DENV is
an enveloped positive single-stranded
RNA virus that belongs to the Flavivir-
idae family. DENV can cause dengue
hemorrhagic fever and dengue shock
syndrome. Vector-mediated transmis-
sion of DENV is initiated when a
blood-feeding female Ae. mosquito
injects saliva, together with the virus,
into the skin of its mammalian host.
Mosquito saliva contains a repertoire
of bioactive components that modulate
the host’s hemostasis and immune
response, thus facilitating blood feed-
ing and pathogen transmission (re-
views in Schneider and Higgs (2008)
and Ribeiro et al. (2010)). It has been
demonstrated that Ae. aegypyi salivary
proteins are immmunosuppressive
and are associated with an increase
of West Nile virus in the skin (Schnei-
der et al., 2010). Moreover, a recent
comparison of cutaneous cytokines
elicited in mice by Chikungunya
virus revealed a reorientation of the
host’s protective TH1 to a TH2 type
immune response by the presence of
the Ae aegypti saliva (Thangamani
et al., 2010). Taken together, these
and other results obtained from
studies in several experimental disease
models, using various arthropod-borne
viruses, demonstrate that saliva is
associated with an increase in virus
pathogenicity (review in Schneider and
Higgs (2008)).
During blood feeding, an infected
mosquito transmits virus in saliva that
is secreted predominantly in the extra-
vascular regions of the uppermost
layer of skin, the epidermis, which
consists primarily of keratinocytes
(Limon-Flores et al., 2005). Whereas
dendritic cells have long been consid-
ered to be the main target of DENV
(Halstead and O’Rourke, 1977), we
have recently demonstrated that hu-
man keratinocytes are permissive to
DENV infection as well. DENV repli-
cation in infected primary human
keratinocytes was found to lead to
activation of antiviral innate immune
responses by activating signaling path-
ways that converge into secretion of
antimicrobial peptides (AMPs) and
IFNs (Surasombatpattana et al., 2011).
Therefore, we investigated the effect of
Ae. aegypti salivary gland extract (SGE) on
DENV infection in human keratinocytes.
Human primary keratinocytes were
infected with DENV in the presence or
absence of Ae. aegypti SGE obtained
from a single pair of salivary glands. At
6 and 24 hours post infection (h.p.i.),
intracellular viral mRNA levels were
quantified by real-time PCR (Figure 1).
The expression levels of DENV tran-
scripts in the infected keratinocytes
were increased in the presence of
SGE, as compared with DENV infec-
tion alone, although not detected
in mock-infected cells. The results
furthermore show that, at 6 h.p.i., the
presence of SGE during the infection
of keratinocytes with DENV strongly
downregulated the expression of human
Abbreviations: Ae., Aedes; AMP, antimicrobial peptide; DENV, dengue virus; h.p.i., hours post infection;
HSV, herpes simplex virus; SGE, salivary gland extraction; SOD2, superoxide dismutase 2
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